Molina Healthcare (MOH) Projected to Post Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is anticipated to post its Q3 2025 results after the market closes on Wednesday, October 22nd. Analysts expect Molina Healthcare to post earnings of $3.82 per share and revenue of $10.9858 billion for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, October 23, 2025 at 8:00 AM ET.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). The firm had revenue of $11.43 billion for the quarter, compared to analysts’ expectations of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company’s quarterly revenue was up 15.7% on a year-over-year basis. During the same period in the previous year, the company earned $5.86 EPS. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $28 EPS for the next fiscal year.

Molina Healthcare Trading Up 2.1%

Shares of MOH opened at $192.47 on Monday. The stock has a market capitalization of $10.43 billion, a P/E ratio of 9.49 and a beta of 0.55. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. The firm has a fifty day simple moving average of $181.93 and a two-hundred day simple moving average of $243.40. Molina Healthcare has a twelve month low of $151.95 and a twelve month high of $359.97.

Analyst Ratings Changes

Several brokerages have weighed in on MOH. Robert W. Baird dropped their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Truist Financial set a $210.00 price target on shares of Molina Healthcare in a research report on Tuesday, October 14th. Wells Fargo & Company increased their price target on shares of Molina Healthcare from $198.00 to $231.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. TD Cowen cut shares of Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 price target for the company. in a research report on Thursday. Finally, Mizuho decreased their price objective on shares of Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating for the company in a report on Friday, July 11th. Three investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and a consensus price target of $222.15.

Insider Transactions at Molina Healthcare

In related news, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares of the company’s stock, valued at $2,633,719.94. This trade represents a 3.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO James Woys purchased 10,000 shares of the stock in a transaction that occurred on Monday, August 4th. The shares were acquired at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the transaction, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.26% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of MOH. Viking Global Investors LP bought a new stake in Molina Healthcare during the 2nd quarter valued at about $79,665,000. Goldman Sachs Group Inc. increased its stake in Molina Healthcare by 19.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock valued at $82,172,000 after purchasing an additional 40,531 shares in the last quarter. Holocene Advisors LP increased its stake in Molina Healthcare by 61.9% during the 2nd quarter. Holocene Advisors LP now owns 128,912 shares of the company’s stock valued at $38,403,000 after purchasing an additional 49,304 shares in the last quarter. Man Group plc increased its stake in Molina Healthcare by 1,551.9% during the 2nd quarter. Man Group plc now owns 127,132 shares of the company’s stock valued at $37,873,000 after purchasing an additional 119,436 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its stake in Molina Healthcare by 77.6% during the 2nd quarter. Adage Capital Partners GP L.L.C. now owns 74,928 shares of the company’s stock valued at $22,321,000 after purchasing an additional 32,728 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.